Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

Dare Bioscience, Inc. (DARE) AI Forecast

Our AI analyzed Dare Bioscience, Inc.. Create a free account and follow it to see the 90-day price prediction.

✓ Free account • ✓ 30-day free trial

$DARE Neutral Signal Full forecast available
Sign Up Free

Dare Bioscience, Inc. (DARE) Stock Forecast 2025

Dare Bioscience, Inc. (DARE) AI Stock Price Forecast & Investment Analysis

Dare Bioscience, Inc. Stock Price Chart and Technical Analysis

Loading chart...

Dare Bioscience, Inc. (DARE) - Comprehensive Stock Analysis & Investment Research

Deep dive into Dare Bioscience, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on July 29, 2026, 12:05 a.m. (UTC)

Dare Bioscience, Inc. Investment Summary

When evaluating whether Dare Bioscience, Inc. (DARE) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Dare Bioscience, Inc. (DARE) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. . With a market capitalization of $19 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.

Financial Performance Analysis

Our comprehensive financial analysis covers Dare Bioscience, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Dare Bioscience, Inc. along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Dare Bioscience, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Dare Bioscience, Inc.

Sign Up Free
Corporate Identity

Dare Bioscience, Inc. (Stock Symbol: DARE) is a prominent company operating within the Life Sciences sector, with a specific focus on the Pharmaceutical Preparations industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Dare Bioscience, Inc.'s leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Dare Bioscience, Inc....

Sector & Industry Analysis

In-depth sector dynamics and industry context for Dare Bioscience, Inc....

Unlock Full Company Profile

Get complete details about Dare Bioscience, Inc.

Sign Up Free
Revenue & Growth Analysis

Dare Bioscience, Inc. generates annual revenues of $1 million , representing an emerging company in its growth phase.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Dare Bioscience, Inc....

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Dare Bioscience, Inc....

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Dare Bioscience, Inc....

Unlock Financial Analysis

Get complete financial metrics for Dare Bioscience, Inc.

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Dare Bioscience, Inc.'s AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Dare Bioscience, Inc. strategically competes in the highly dynamic Pharmaceutical Preparations marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.

Industry Competitive Landscape

Dare Bioscience, Inc. competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company currently shows negative free cash flow of $-10 million . Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.

Asset Utilization Efficiency

Asset turnover ratio of 0.04x indicates lower asset turnover that may reflect the industry's capital-intensive nature or potentially underutilized assets. Companies with low turnover typically depend on strong margins to generate adequate returns on capital.

Financial Strength & Leverage

Dare Bioscience, Inc. (DARE) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Dare Bioscience, Inc. stock analysis.

Deep dive into Dare Bioscience, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Dare Bioscience, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Dare Bioscience, Inc.:

P/B Ratio 26.17x
Market Cap $19M
Book Value/Share $0.05
Revenue/Share $0.08
FCF/Share $-0.70
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Dare Bioscience, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Dare Bioscience, Inc.: An ROE of -55199.3% indicates room for improvement in shareholder value creation.

ROE -55199.3%
ROA -1456.8%
Net Margin -5906.4%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Dare Bioscience, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Dare Bioscience, Inc.:

D/E Ratio 36.89x
Financial Leverage 37.89x
Interest Coverage 51.3x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Dare Bioscience, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Dare Bioscience, Inc.: Free cash flow of $-10M indicates cash challenges that need attention.

Operating Cash Flow -$377M
Free Cash Flow -$10M
Capital Spending $367M
FCF/Sales -878.3%
CapEx/Sales 31723.3%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Dare Bioscience, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Dare Bioscience, Inc.: An asset turnover of 0.04x suggests room for improvement in asset utilization.

Asset Turnover 0.04x
Understanding Financial Statement Data

What these metrics mean: Key figures from Dare Bioscience, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Dare Bioscience, Inc.: With annual revenue of $1M, Dare Bioscience, Inc. represents a smaller but potentially high-growth operation.

Income Statement
Total Revenue $1M
Net Income -$405M
R&D Expense $274M
Balance Sheet Highlights (% Of Assets)
Total Liabilities 27%
Dividend & Shareholder Information
Shares Outstanding 15M
Growth Metrics (YoY)
Net Income Growth -5906.4%

Latest Dare Bioscience, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Dare Bioscience, Inc. (DARE) stock price and investment outlook.

📰 Loading...

Dare Bioscience, Inc. Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of Dare Bioscience, Inc. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AARD ██% $140M x 1.6x
ABBV ██% $466.15B 128.2x x
ABCL ██% $1.61B x 1.7x
ABEO ██% $342M 5.2x 2.4x
ABT ██% $186.84B 29.8x 3.6x
ABUS ██% $869M 5.4x 3.3x
ABVC ██% $27M x 2.5x
ABVX ██% $9.76B x x
ACAD ██% $4.45B 11.9x 3.6x
ACET ██% $77M x 0.6x
ACRS ██% $744M x 5.2x
ACRV ██% $60M x 0.6x
ACUT ██% $4M x x
ACXP ██% $6M x 0.9x
ADAG ██% $246M x 6.5x
ADCT ██% $141M x x
ADIL ██% $6M x 1.7x
ADTX ██% $3M x x
ADXN ██% $7M x x
AEON ██% $11M x x
AGIO ██% $2.14B x 1.9x
AKBA ██% $340M x 12.4x
AKTX ██% $15M x 1.0x
ALDX ██% $95M x 2.3x
ALKS ██% $8.46B 128.0x 4.7x
ALLR ██% $19M x 2.7x
ALMS ██% $3.38B x 6.0x
ALNY ██% $38.18B 121.7x 48.4x
ALT ██% $581M x 2.1x
ALXO ██% $268M x 1.8x
ALZN ██% $5M x 6.8x
AMLX ██% $2.17B x 8.0x
AMPH ██% $899M 11.4x 1.2x
AMRN ██% $293M x 0.7x
AMRX ██% $5.93B 48.6x x
ANAB ██% $1.51B x 118.7x
ANEB ██% $14M x 1.7x
ANIP ██% $1.69B 18.4x 3.0x
ANIX ██% $119M x 8.3x
ANNX ██% $757M x 3.7x
ANRO ██% $961M x 4.0x
ANTX ██% $169M x 2.1x
ANVS ██% $72M x 23.0x
APLM ██% $40M x x
APRE ██% $7M x 0.2x
APUS ██% $12M x 0.1x
APVO ██% $5M x 0.4x
AQST ██% $467M x x
ARCT ██% $163M x 0.9x
ARDX ██% $1.26B x 8.5x
ARQT ██% $3.55B x 18.7x
ARTL ██% $3M x 0.5x
ARVN ██% $529M x 1.4x
ARWR ██% $12.06B x 19.6x
ASBP ██% $9M x 2.4x
ASMB ██% $507M x 2.6x
ASND ██% $15.77B x x
ASRT ██% $151M x 2.0x
ATAI ██% $2.66B x 16.6x
ATHE ██% $83M x x
ATNM ██% $27M x 11.8x
ATOS ██% $24M x 0.8x
ATXI ██% $990K x 0.8x
AUPH ██% $1.96B 6.6x 3.5x
AVBP ██% $1.36B x 4.2x
AVIR ██% $361M x 1.5x
AVTX ██% $1.03B x 15.1x
AXIM ██% $1M x x
AXSM ██% $12.04B x 220.6x
AZTR ██% $2M x 0.2x
BBIO ██% $16.74B x x
BBOT ██% $688M x 1.9x
BCAX ██% $1.76B x 3.4x
BCTX ██% $30M x 1.3x
BCYC ██% $275M x 0.5x
BDPT ██% $30K x x
BDRX ██% $1M x x
BFRG ██% $11M x 2.2x
BFRI ██% $13M x 2.2x
BHC ██% $1.69B x x
BHST ██% $46M x 1.8x
BIOA ██% $973M x 2.6x
BIOE ██% $13M 9.7x x
BIOM ██% $380K x x
BIVI ██% $10M x 0.6x
BIXT ██% $3M x x
BLRX ██% $13M x x
BLTE ██% $6.14B x 8.0x
BMEA ██% $90M x 4.8x
BMRN ██% $12.00B 44.6x 1.9x
BMY ██% $129.62B 17.8x 6.5x
BNTC ██% $408M x 2.2x
BOLD ██% $55M x 0.6x
BOLT ██% $8M x 0.4x
BPTH ██% $2M x x
BQST ██% $2M x x
BRNS ██% $23M x 0.4x
BSPK ██% $10K x x
BTAI ██% $26M x x
BYSI ██% $49M x x
CALC ██% $11M x x
CANF ██% $7M x 1.2x
CAPR ██% $379M x 1.4x
CATX ██% $327M x 0.9x
CBIO ██% $608M x 6.0x
CDT ██% $2M x x
CING ██% $61M x 3.2x
CLCS ██% $65M x x
CLNN ██% $64M x x
CLRB ██% $20M x 5.9x
CLSDQ ██% $1M x x
CLYM ██% $732M x 5.0x
CMMB ██% $10M x 0.8x
CMND ██% $2M x x
CMPS ██% $1.52B x 4.7x
CNBX ██% N/A x x
CNSP ██% $7M x 104.8x
CNTA ██% $6.27B x 12.9x
CNTB ██% $132M x 3.1x
CNTX ██% $57M x 1.1x
COCP ██% $13M x 3.2x
COGT ██% $6.91B x 11.4x
COLL ██% $1.16B 15.5x 3.7x
CORT ██% $9.52B 201.0x 14.9x
COYA ██% $100M x 2.0x
CPHI ██% $50M x 1.4x
CPIX ██% $103M x 4.8x
CPMD ██% $1M x x
CPRX ██% $3.85B 17.4x 3.8x
CRBP ██% $161M x 1.3x
CRMD ██% $596M 3.3x 1.4x
CRNX ██% $8.83B x 6.9x
CRVO ██% $25M x 2.3x
CRVS ██% $1.09B x 4.5x
CTMX ██% $708M x 2.2x
CTNM ██% $518M x 2.1x
CTOR ██% $52M x 1.5x
CTTH ██% $4M x 5.3x
CTXR ██% $14M x 0.2x
CUE ██% $131M x 6.1x
CURX ██% $5M x 0.6x
CVKD ██% $6M x 3.6x
CVSI ██% $4M x 2.6x
CYCN ██% $15M x 2.2x
CYDY ██% $270M x x
CYPH ██% $67M x 0.8x
CYRX ██% $766M 9.6x 1.6x
CYTK ██% $10.95B x x
DARE ██% $19M x 26.2x
DCOY ██% $2M x 0.5x
DERM ██% $174M x 5.6x
DMAC ██% $363M x 7.7x
DMRA ██% $1.80B x 3.5x
DNTH ██% $5.70B x 4.8x
DRMA ██% $5M x 0.8x
DRUG ██% $706M x x
DSGN ██% $742M x 3.4x
DWTX ██% $51M x 0.6x
DYN ██% $4.23B x 4.9x
EBS ██% $380M x 0.7x
EDSA ██% $48M x 4.7x
ELAB ██% $4M x 0.3x
ELAN ██% $12.69B x 2.0x
ELDN ██% $271M x 6.1x
ELTP ██% $409M 9.1x 4.1x
ELTX ██% $79M x x
ELVN ██% $3.77B x 8.3x
EMMA ██% $820K x x
ENLV ██% $72M 0.0x 0.0x
ENSC ██% $4M x x
ENTA ██% $370M x 3.2x
ENVB ██% $5M x 1.1x
EOLS ██% $401M x x
EPRX ██% $403M x 4.9x
EQ ██% $149M x 2.5x
ERAS ██% $6.55B x 16.6x
ERNA ██% $5M x 0.7x
ESPR ██% $799M x x
ETON ██% $1.16B x 37.8x
ETST ██% $35M 7.2x 5.0x
EVFM ██% $1M x x
EVMN ██% $413M x 1.4x
EWTX ██% $4.35B x 8.8x
FBIO ██% $109M 0.9x 0.7x
FBLG ██% $3M x 1.3x
FBRX ██% $1.57B x 37.3x
FHTX ██% $305M x x
FLNA ██% $44M x 0.6x
FTH ██% $754M x x
FULC ██% $248M x 0.7x
GALT ██% $223M x x
GANX ██% $79M x 5.6x
GCAN ██% $260K x x
GDTC ██% $11M x x
GERN ██% $956M x 4.2x
GHRS ██% $1.73B x x
GLMD ██% $3M x 0.2x
GLSI ██% $197M x 37.4x
GNLX ██% $132M x 5.8x
GNPX ██% $4M x 0.2x
GOSS ██% $97M x x
GOVX ██% $4M x 2.3x
GPCR ██% $3.46B x 2.4x
GRCE ██% $38M x 0.6x
GRI ██% $2M x 0.2x
GRTX ██% $3.38B 22.7x 4646.0x
GSK ██% $104.11B x x
GTBP ██% $12M x 1.6x
GYRE ██% $683M x 6.8x
HCM ██% $1.92B 2.1x 1.6x
HCWB ██% $4M x 0.8x
HELP ██% $477M x x
HEPA ██% $1M x 0.7x
HIND ██% $14M x 2.1x
HOOK ██% $14M x 0.4x
HOWL ██% $22M x 1.8x
HRMY ██% $2.06B 14.2x 2.3x
HRTX ██% $87M x 9.6x
HSTC ██% $99M x 79.9x
HURA ██% $141M x 6.1x
HYFT ██% $67M x x
HYPD ██% $39M x 0.7x
IBIO ██% $72M x 0.9x
IBO ██% $47M x 4.1x
IDYA ██% $3.16B x 3.4x
IFRX ██% $250M x x
IGC ██% $26M x 4.2x
IMMP ██% $56M x x
IMMX ██% $619M x 7.3x
IMNM ██% $2.56B x 4.3x
IMNN ██% $6M x 1.8x
IMRN ██% $9M x x
IMRX ██% $282M x 1.4x
IMUX ██% $188M x 1.2x
INBP ██% $5M x 0.3x
INDP ██% $272M x 217.8x
INDV ██% $4.96B 19.7x x
INM ██% $9M x 1.3x
INO ██% $80M x 13.2x
INSM ██% $22.68B x 32.2x
INTI ██% $14M x x
INVA ██% $1.62B 3.2x 1.2x
IOBTQ ██% $70K x 0.1x
IONS ██% $9.28B x 18.9x
IRD ██% $277M x x
IRON ██% $2.82B x 4.1x
IRWD ██% $644M 6.3x x
ISCO ██% $2M x x
IVA ██% $1.09B x x
IXHL ██% $36M x 0.5x
JAGX ██% $5M x x
JANX ██% $948M x 1.0x
JAZZ ██% $15.81B 536.1x 3.5x
JBIO ██% $1.21B x 4.1x
JNJ ██% $640.25B 30.4x 7.5x
JUNS ██% $6M x x
KALA ██% $12M x 1.2x
KALV ██% $1.38B x x
KAPA ██% $7M x 1.3x
KAYS ██% $210K x x
KMDA ██% $403M x x
KNSA ██% $4.86B 66.5x 8.0x
KPRX ██% $10M x 0.7x
KPTI ██% $160M x x
KROS ██% $201M x 0.7x
KRRO ██% $155M x 1.3x
KTTA ██% $15M x 0.3x
KURA ██% $825M x 7.6x
KYNB ██% $29M 0.2x x
LAB ██% $300M 3.8x 0.5x
LBRX ██% $997M x 2.6x
LEGN ██% $3.73B x x
LEXX ██% $13M x 2.7x
LFCR ██% $163M x x
LFVN ██% $80M 10.2x 2.4x
LGND ██% $5.96B 38.8x 6.0x
LGVN ██% $19M x 1.2x
LIANY ██% $12M x 0.1x
LIFD ██% $3M x 0.4x
LIPO ██% $150K x 0.1x
LITS ██% $34M x 0.6x
LIXT ██% $120M x 15.2x
LKFT ██% $1.85B x x
LLY ██% $1.09T 43.3x 35.1x
LNAI ██% $10M x x
LPCN ██% $16M x 0.7x
LQDA ██% $7.46B 334.2x 68.7x
LRMR ██% $394M x 2.5x
LSTA ██% $13M x 1.2x
LTRN ██% $36M x 10.3x
LXRX ██% $994M x 4.9x
LYEL ██% $302M x 1.1x
MAIA ██% $78M x 2.8x
MANE ██% $4.65B x 11.9x
MBIO ██% $4M x 0.5x
MBRX ██% $15M x 1.0x
MBX ██% $2.92B x 6.7x
MCRB ██% $47M x 1.8x
MDCX ██% $18M x 13.6x
MDGL ██% $12.70B x 23.4x
MGNX ██% $254M x 12.0x
MIRA ██% $37M x 4.0x
MIRM ██% $6.96B x 28.7x
MIST ██% $133M x 3.7x
MLTX ██% $1.69B x 6.7x
MLYS ██% $2.24B x 3.5x
MNKD ██% $1.22B x x
MNOV ██% $65M x 1.7x
MNPR ██% $739M x 5.5x
MPLT ██% $448M x 1.1x
MREO ██% $48M x 1.4x
MRK ██% $323.24B 36.2x 7.1x
MRKR ██% $20M x 1.5x
MRVI ██% $2.47B x 11.7x
MSLE ██% $197M x x
MTNB ██% $2M x 0.7x
MTVA ██% $7M x 0.8x
NAMS ██% $3.52B x 5.3x
NATR ██% $362M 18.2x 2.2x
NBP ██% $206M x 0.8x
NBTX ██% $1.95B x x
NCEL ██% $19M x 35.7x
NCNA ██% $5M x x
NERV ██% $184M x x
NEUP ██% $21M x 0.7x
NGNE ██% $691M x 2.9x
NIKA ██% $806M x x
NKTR ██% $2.41B x 4.2x
NKTX ██% $168M x 0.6x
NMAD ██% $81M x 10.2x
NNVC ██% $39M x 4.3x
NRIX ██% $2.43B x 6.0x
NRSN ██% $21M x x
NRXP ██% $155M x x
NSRX ██% $36M x 13.1x
NTHI ██% $85M x x
NUVB ██% $2.31B x 7.2x
NUVL ██% $9.75B x 8.3x
NVCT ██% $616M x 43.3x
NVS ██% $297.88B x x
NWBO ██% $273M x x
NXTC ██% $21M x 0.8x
NXTS ██% $2M x 0.2x
OCUL ██% $1.89B x 3.3x
OGEN ██% $2M x 0.4x
OGI ██% $132M x x
OGN ██% $3.56B 14.5x 3.9x
OKUR ██% $164M x 0.9x
OLMA ██% $1.05B x 2.2x
OMER ██% $816M 9.5x x
ONC ██% $33.81B 65.9x 7.1x
ONCO ██% $3M x 0.3x
ONCY ██% $93M x x
OPK ██% $937M x 0.8x
ORGO ██% $328M 120.7x 1.3x
ORIC ██% $1.24B x 3.0x
ORKA ██% $5.44B x 11.2x
ORMP ██% $170M 1.6x 0.7x
OSTX ██% $70M x x
OTLC ██% $18M x 0.1x
OVID ██% $439M x 2.2x
OWPC ██% $70K x x
PAHC ██% $1.43B 15.0x 4.0x
PBH ██% $2.44B 12.8x 1.3x
PBM ██% $12M x x
PBYI ██% $407M 16.7x 3.2x
PCRX ██% $1.04B 202.5x 1.6x
PCSA ██% $7M x 2.7x
PCYN ██% $2M x 1.0x
PDSB ██% $39M x 9.9x
PEPG ██% $131M x 1.0x
PFE ██% $140.40B 18.7x 1.6x
PGEN ██% $1.93B x 95.3x
PHAT ██% $949M x x
PHIO ██% $12M x 0.7x
PHVS ██% $2.37B x x
PKTX ██% $3M x 10.3x
PLRX ██% $67M x 0.4x
PLYX ██% $93M x 37.3x
PMHS ██% $2M x x
PMN ██% $105M x 1.7x
PMVP ██% $63M x 0.7x
PPBT ██% $1M x x
PPCB ██% $3M x 0.3x
PRAX ██% $8.80B x 6.2x
PRFX ██% $3M x 0.4x
PRGO ██% $1.40B x 0.6x
PRLD ██% $321M x 5.3x
PRPH ██% $840K x 0.1x
PRQR ██% $244M x x
PRTA ██% $462M x 1.5x
PTCT ██% $6.28B x x
PTGX ██% $8.71B x 13.3x
PTIX ██% $420K x x
PTN ██% $14M x 1.3x
PTPI ██% $170K 0.0x 0.1x
PULM ██% $6M x 1.8x
PVCT ██% $25M x x
PVLA ██% $2.03B x 8.7x
PYXS ██% $183M x 5.9x
QNRX ██% $9M x 1.0x
QNTM ██% $19M x x
QTTB ██% $452M 13.6x 9.8x
QUCY ██% $25M x 5.5x
QURE ██% $2.41B x 16.1x
RADX ██% $29M x x
RANI ██% $111M x 3.9x
RAPP ██% $2.01B x 4.3x
RARE ██% $2.64B x x
RCKT ██% $355M x 1.5x
RCUS ██% $3.49B x 6.7x
RDY ██% $9.82B x x
REGN ██% $69.39B 15.7x 2.2x
REVB ██% $4M x 0.3x
RFL ██% $121M x 1.6x
RGBP ██% $50K x x
RIGL ██% $688M 1.9x 1.7x
RKTO ██% $17M x 4.1x
RLMD ██% $546M x 2.5x
RLYB ██% $86M x 1.7x
RMHI ██% $25M x x
RMTI ██% $29M x 0.8x
RNAC ██% $212M x x
RNAZ ██% $5M x 4.0x
RNTX ██% $67M x 5.8x
RNXT ██% $42M x 3.7x
ROIV ██% $25.01B x 5.5x
RPRX ██% $33.82B 40.9x 4.9x
RTEZ ██% $1.93B x x
RVPH ██% $7M x 0.4x
RVRC ██% $101M x 16.5x
RYTM ██% $7.26B x 59.1x
RZLT ██% $478M x 4.1x
SBFM ██% $2M x 0.1x
SCNX ██% $15M x 0.2x
SCYX ██% $284M x 6.9x
SDEV ██% $30M 0.1x 0.2x
SDGR ██% $1.13B x 3.6x
SEPN ██% $1.50B x 4.0x
SER ██% $31M x 1.8x
SGMT ██% $460M x 4.5x
SHPH ██% $2M x 0.5x
SIGA ██% $222M 11.0x 1.5x
SILO ██% $5M x 0.9x
SION ██% $2.05B x 7.1x
SKVI ██% $1M x x
SKYE ██% $22M x 2.4x
SLGL ██% $259M x 11.4x
SLN ██% $570M x 11.5x
SLS ██% $1.97B x 18.3x
SMMT ██% $10.39B x 16.5x
SMNR ██% $145M x x
SNDX ██% $1.80B x 43.1x
SNGX ██% $5M x 1.7x
SNSE ██% $31M x x
SNY ██% $108.63B x x
SPRB ██% $116M x 3.3x
SPRC ██% $3M x x
SPRO ██% $70M 4.6x 1.3x
SPRY ██% $572M x 9.3x
SRPT ██% $1.67B 25.8x 1.1x
STOK ██% $1.85B x 4.7x
STTK ██% $670M x 7.0x
SUPN ██% $2.73B x 2.5x
SVRA ██% $1.10B x 6.2x
SXTP ██% $4M x 0.8x
SYBX ██% $7M x 0.6x
SYRE ██% $7.58B x 11.3x
TAK ██% $56.43B x x
TBPH ██% $870M 7.6x 3.0x
TCRT ██% $4M x 3.5x
TELO ██% $82M x 16.5x
TENX ██% $411M x 3.6x
TEVA ██% $36.52B 23.3x 4.4x
TGTX ██% $8.54B 18.5x 14.7x
TLPH ██% $63M x 3.4x
TLX ██% $3.41B x x
TNGX ██% $4.16B x 10.6x
TNXP ██% $161M x 0.7x
TOVX ██% $10M x 0.6x
TPST ██% $15M x 17.9x
TRDA ██% $228M x 0.8x
TRVI ██% $2.32B x 13.5x
TTRX ██% $238M x 38.9x
TVRD ██% $23M x 1.6x
TVTX ██% $5.16B x 52.2x
TXMD ██% $24M 131.9x 0.9x
TYRA ██% $1.85B x 4.8x
UNCY ██% $126M x 3.4x
UPB ██% $333M x 1.1x
URGN ██% $1.99B x x
UTHR ██% $26.28B 20.4x 4.5x
VBIO ██% $890K x 0.1x
VCNX ██% $3M x x
VERA ██% $2.40B x 4.8x
VGLS ██% $240K x x
VICP ██% $47M x x
VKTX ██% $3.84B x 7.6x
VNDA ██% $308M x 1.1x
VRCA ██% $99M x 6.2x
VRDN ██% $1.99B x 3.1x
VREOD ██% $491M x 1.7x
VREOF ██% $491M x 1.7x
VRTX ██% $122.80B 28.3x 6.3x
VSTM ██% $542M x 6.6x
VTGN ██% $9M x 0.3x
VTRS ██% $20.60B x 1.4x
VYNE ██% $19M x 0.8x
WHWK ██% $166M x 1.4x
WVE ██% $1.13B x 2.2x
XBIO ██% $6M x 0.8x
XBIT ██% $70M x 0.5x
XCUR ██% $10M x 5.0x
XENE ██% $6.29B x 4.7x
XERS ██% $1.43B 118.9x 109.8x
XLO ██% $60M x 0.8x
XNCR ██% $1.44B x 2.8x
XOMA ██% $710M 21.0x 7.7x
XTLB ██% $7M x x
ZBIO ██% $2.03B x 6.0x
ZLAB ██% $2.10B x 3.2x
ZNTL ██% $322M x 1.8x
ZTS ██% $32.57B 12.3x 10.1x
ZVRA ██% $568M 4.6x 2.8x
ZVSA ██% $940K x x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Dare Bioscience, Inc. Stock Forecast

How accurate are Dare Bioscience, Inc. stock predictions?

Our AI model shows a 11% Spearman correlation coefficient for DARE predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Dare Bioscience, Inc. stock price forecasts?

Our analysis considers Dare Bioscience, Inc.'s financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Dare Bioscience, Inc. a good investment in 2025?

Based on our AI analysis, Dare Bioscience, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Dare Bioscience, Inc. forecasts updated?

Dare Bioscience, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Dare Bioscience, Inc.?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...